The personal genomics product supplier has closed a round featuring corporates Illumina and Mayo Clinic after receiving funding from Temasek.

US-based personal genomics platform operator Helix closed a series B round featuring genomics technology producer Illumina and medical research and services provider Mayo Clinic at $200m yesterday.

The round was closed out with an investment by Singaporean state-owned firm Temasek. It was led by DFJ and also featured fellow venture capital firm Kleiner Perkins Caufield & Byers and private equity firms Sutter Hill Ventures and Warburg Pincus.

Helix runs an online marketplace where personal genomics products and services can be…